logo
logo

Tesseract Health Closes Oversubscribed $80 Million Series B Financing

Apr 20, 2021•about 4 years ago

Amount Raised

$80 Million

Round Type

series b

Guilford

Description

Tesseract HealthTM Inc. has raised $80 million in an oversubscribed Series B financing round -- with support from investors including Foresite Capital, Glenview Capital, and Opaleye -- to advance the development of the company’s groundbreaking Tesseract iCTM eye-imaging diagnostic technology platform. The funds will be used to conduct research to advance the Tesseract iC platform, accelerate the company’s push to obtain US and international regulatory clearances, and ramp up manufacturing. The funds will also be used to further enhance Tesseract’s unique AI capabilities and prepare the company for commercial launch.

Company Information

Company

Tesseract Health Tm

Location

Guilford, North Carolina, United States

About

Tesseract Health’s mission is to democratize healthcare and improve lives using the wealth of health information in the human eye. Tesseract knows that the best way to predict the future is to make it, and that the retina will be the new noninvasive diagnostic platform of the 21st century. This future will be made possible by Tesseract Health and its innovative Tesseract iC platform incorporating novel multidimensional sensors and artificial intelligence. Tesseract Health is part of 4Catalyzer, a rapidly growing health technology accelerator with offices in CT, NY, CA, and Taiwan, and offices opening soon in Miami, Boston, and San Diego. Other notable 4Catalyzer companies include Butterfly Network (NYSE: BFLY), Quantum-Si (NASDAQ: CAPA/QSI), and Hyperfine.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech